Bassam Estfan, MD
Hospice and Palliative Medicine · Cleveland, OHNPI 1821298035
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $13,600 of the $20,293 with a category attached, or 67.0%. AstraZeneca accounts for 83.1% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2023 at $16,018 and has fallen 80.9% since, to $3,066 in 2024. Among hospice and palliative medicine clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 26 payments — averaging $780.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$17K
- Sirtex Medical Inc$3K
- Histosonics, Inc.$185
- Incyte Corporation$125
- Seagen Inc.$118
- Dova Pharmaceuticals$104
- plus $209 from 3 others
Across 86 payments — averaging $4705.07 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AstraZeneca$160K
- Incyte Corporation$93K
- Servier Bioinnovation$78K
- Amgen$74K
What the payments were for
- Consulting fees$4,65523%
- Speaking & faculty fees$13,60067%
- Travel & lodging$5553%
- Food & beverage$1,4837%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $16,857 |
| Sirtex Medical Inc | 2 | $2,695 |
| Histosonics, Inc. | 1 | $185 |
| Incyte Corporation | 1 | $125 |
| Seagen Inc. | 1 | $118 |
| Dova Pharmaceuticals | 1 | $104 |
| E.r. Squibb & Sons, L.L.C. | 1 | $80 |
| Medtronic | 1 | $67 |
| Advanced Accelerator Applications | 2 | $63 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- IMFINZI$16,253
- SIR-Spheres Microspheres$2,600
- PEMAZYRE$125
- TUKYSA$118
- DOPTELET$104
How this compares
$20,293 in reported general payments places this provider in the 95th percentile of 88 hospice and palliative medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 11 | $7,610 |
| Olanzapine | 21 | $356 |
| Ondansetron Hcl | 31 | $226 |
| Prochlorperazine Maleate | 18 | $160 |
| Pantoprazole Sodium | 12 | $124 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 15 | $117 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 11 | $45 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Cleveland
- John LeeCleveland$4K
- Ana Siu ChangCleveland$1K
- Ahed MakhoulCleveland$1K
- Mona GuptaCleveland$668
- Alexander BeylinsonCleveland$495
- Joseph ParenteauCleveland$269
- Allison EarlyCleveland$265
- Kevin LiuCleveland$161
- Candace LeighCleveland$133
- Joanna ChenCleveland$132
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.